Plasma protein biomarkers predict both the development of persistent autoantibodies and type 1 diabetes 6 months prior to the onset of autoimmunity: the TEDDY Study
Nakayasu, E. S.; Bramer, L.; Ansong, C.; Schepmoes, A.; Fillmore, T.; Gritsenko, M.; Clauss, T.; Gao, Y.; Piehowski, P.; Stafill, B.; Engel, D.; Orton, D.; Moore, R.; Qian, W.-J.; Sechi, S.; Frohnert, B.; Toppari, J.; Ziegler, A.; Lernmark, A.; Hagopian, W.; Akolkar, B.; Smith, R. D.; Rewers, M.; Webb-Robertson, B.-J.; Metz, T. O.
Show abstract
Type 1 diabetes (T1D) results from an autoimmune destruction of pancreatic {beta} cells. A significant gap in understanding the disease cause is the lack of predictive biomarkers for each of its developmental stages. Here, we conducted a blinded, two-phase case-control plasma proteomics analysis of children enrolled in the TEDDY study to identify biomarkers predictive of autoimmunity and T1D development. First, we performed untargeted proteomics analyses of 2,252 samples from 184 individuals and identified 376 regulated proteins. Complement/coagulation, inflammatory signaling and metabolic proteins were regulated even prior to autoimmunity onset. Extracellular matrix proteins and antigen presentation were differentially regulated in individuals with autoimmunity who progressed to T1D versus those who maintained normoglycemia. We then performed targeted proteomics measurements of 167 proteins in 6,426 samples from 990 individuals and validated 83 biomarkers. A machine learning analysis predicted both the development of persistent autoantibodies and T1D onset 6 months before autoimmunity initiation, with an area under the receiver operating characteristic curve of 0.871 and 0.918, respectively. Our study identified and validated biomarkers highlighting pathways affected in different stages of T1D development.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Optimised proteomic analysis of insulin granules from MIN6 β-cells identifies Scamp3, a novel regulator of insulin secretion and content 95%
- Polysaccharide A-dependent opposing effects of mucosal and systemic exposures to human gut commensal Bacteroides fragilis in type 1 diabetes 93%
- Improved specificity of glutamate decarboxylase 65 autoantibody measurement using luciferase-based immunoprecipitation system (LIPS) assays 92%
Similar papers in this journal
- Increased expression of viral sensor MDA5 in pancreatic islets and in hormone-negative endocrine cells in recent onset type 1 diabetic donors 93%
- Proteomic and metabolomic signatures associated with the immune response in healthy individuals immunized with an inactivated SARS-CoV-2 vaccine 92%
- Underlying co morbidity reveals unique immune signatures in Type II diabetes patients infected with SARS-CoV2 92%
Similar papers in this journal
- Organ-specific metabolic pathways distinguish prediabetes, type 2 diabetes and normal tissues 95%
- Dynamics of gut microbiome – mediated bile acid metabolism in progression to islet autoimmunity 90%
- Neuroactive metabolites and bile acids are altered in extremely premature infants with brain injury 90%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.